These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8497763)

  • 21. [Long term follow up after parenteral specific hyposensitization in children (author's transl)].
    Urbanek R; Karitzky D
    Klin Padiatr; 1975 Nov; 187(6):513-7. PubMed ID: 1240550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
    Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A
    J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials.
    Senti G; Freiburghaus AU; Kundig TM
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):582-6. PubMed ID: 20827178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
    Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
    Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possibilities and limitations of hyposensitization treatment in airway allergies].
    Wahn U
    Ther Umsch; 1989 Sep; 46(9):625-32. PubMed ID: 2678573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyposensitization (immunotherapy) in allergic diseases: an introduction.
    Fuchs E
    Allergol Immunopathol (Madr); 1981; Suppl 9():167-70. PubMed ID: 7349726
    [No Abstract]   [Full Text] [Related]  

  • 32. [Specific hyposensitization in allergic diseases (author's transl)].
    Kersten W; Kasperski J; Worth G
    Dtsch Med Wochenschr; 1977 Dec; 102(51):1877-81. PubMed ID: 618363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of allergen immunotherapy: a literature review.
    Cook PR; Farias C
    Ear Nose Throat J; 1998 May; 77(5):378-9, 383-8. PubMed ID: 9615518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H; White P; Annila I; Poole J; Andre C; Frew A
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergy evaluation and immunotherapy.
    Pongracic J; Evans R
    Adolesc Med; 2000 Oct; 11(3):521-33. PubMed ID: 11060551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of accelerated hyposensitization with mixed allergens in severe childhood asthma].
    Just J; Bodart E; Pothel E; Boulé M; Grimfeld A; Tournier G
    Ann Pediatr (Paris); 1992 Apr; 39(4):236-40. PubMed ID: 1616237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy for allergic diseases.
    Tipton WR
    Prim Care; 1987 Sep; 14(3):623-9. PubMed ID: 3313465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. There is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitization therapy.
    Netterlid E; Hindsén M; Björk J; Ekqvist S; Güner N; Henricson KA; Bruze M
    Contact Dermatitis; 2009 Jan; 60(1):41-9. PubMed ID: 19125720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.